Physician profile
Rishabh Nikhil Shah
NPI 1134462153
$11,047.46
in general payments reported to CMS, 2019-2025
19 companies · $193 in 2025
The $193 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $1,221 · 2021: $7,448 · 2022: $191 · 2023: $513 · 2024: $1,482 · 2025: $193.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,129 · Food and Beverage: $1,043 · Gift: $16.25.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,128.59 |
| Food and Beverage | $1,042.62 |
| Gift | $16.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $10,167.99 | 2020-2024 | Da Vinci Surgical System |
| Smith+Nephew, INC. | $225.33 | 2022-2025 | Stravix, Oasis, Grafix Xc |
| Medtronic, INC. | $148.33 | 2021-2024 | Ligasure, Dextile, Signia |
| Endogastric Solutions, INC | $84.48 | 2021-2022 | |
| Kvk-Tech, INC. | $72.24 | 2025 | |
| Stryker Corporation | $53.51 | 2020 | |
| Abbvie INC. | $41.93 | 2021 | |
| Teleflex LLC | $36.64 | 2024-2025 | Titan Sgs, Titan Sgs Bailout Chuck |
| Novo Nordisk INC | $29.24 | 2021 | |
| Merck Sharp & Dohme LLC | $24.48 | 2021 | |
| Acera Surgical, INC. | $23.91 | 2025 | Restrata Wound Matrix |
| Covidien LP | $23.75 | 2020 | |
| Lucid Diagnostics INC. | $20.11 | 2023 | |
| Ethicon US, LLC | $18.58 | 2022 | |
| Sanara Medtech INC. | $17.99 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioventus LLC | $15.78 | 2022 | |
| Lifenet Health | $15.23 | 2023 | |
| Convatec INC. | $14.11 | 2022 | |
| Integra Lifesciences Corporation | $13.83 | 2025 | Integra, Surgimend, Integra Dermal Regeneration Template |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rishabh Shah listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.